Human Samples and Data Repository
|ClinicalTrials.gov Identifier: NCT00539370|
Recruitment Status : Completed
First Posted : October 4, 2007
Last Update Posted : June 14, 2012
This protocol will enable IRB (institutional review board) review of proposed research using human samples and data collected under the terminated NIH studies 04-EI-0065 and 96-EI-0096. Data and samples may include demographic and personal health information, psychological or psychiatric testing, blood, urine, CSF or other body fluids or tissues and results of medical and physiological evaluation and medical imaging.
Data and sample analyses are limited to those approved under the original protocols unless additional specific institutional review board approval is obtained.
|Condition or disease|
Objective: This protocol will enable prospective IRB review of research using human samples and data collected under other branch protocols.
Study population: Participants that were followed in terminated branch protocols under which data or samples were collected.
Design: Samples and data will be brought under this protocol, analyzed and stored for uses specified in the original protocols and as additionally approved by the IRB.
Outcome: The outcome of this protocol will be the storage, tracking, and utilization of samples and data obtained under terminated protocols.
|Study Type :||Observational|
|Enrollment :||0 participants|
|Official Title:||Laboratory of Immunology/National Eye Institute Repository|
|Study Start Date :||August 2007|
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00539370
|United States, Maryland|
|National Institutes of Health Clinical Center, 9000 Rockville Pike|
|Bethesda, Maryland, United States, 20892|
|Principal Investigator:||Robert B Nussenblatt, M.D.||National Eye Institute (NEI)|